Managing fatigue in patients with Parkinson's disease: a patient-focused perspective

References

• Finsterer J, Mahjoub SZ. Fatigue in healthy and diseased individuals. Am J Hosp Palliat Care. 2014;31(5):562–575.
   PubMed Web of Science ®Google Scholar
• Bower JE. Fatigue, brain, behavior, and immunity: summary of the 2012 Named Series on fatigue. Brain BehavI Immun. 2012;26(8):1220–1223.
   PubMed Web of Science ®Google Scholar
• Akbar U, Friedman JH. Recognition and treatment of neuropsychiatric disturbances in Parkinson’s disease. Expert Rev Neurother. 2015;15(9):1053–1065.
   PubMed Web of Science ®Google Scholar
• Zingone F, Swift GL, Card TR, Sanders DS, Ludvigsson JF, Bai JC. Psychological morbidity of celiac disease: a review of the literature. United European Gastroenterol J. 2015;3(2):136–145.
   PubMed Web of Science ®Google Scholar
• Kwakkenbos L, Delisle VC, Fox RS, et al. Psychosocial aspects of scleroderma. Rheum Dis Clin North Am. 2015;41(3):519–528.
   PubMed Web of Science ®Google Scholar
• Friedman JH, Brown RG, Comella C, et al. Fatigue in Parkinson’s disease: a review. Mov Disord. 2007;22(3):297–308.
   PubMed Web of Science ®Google Scholar
• van Hilten JJ, Hoogland G, van der Velde EA, Middelkoop HA, Kerkhof GA, Roos RA. Diurnal effects of motor activity and fatigue in Parkinson’s disease. J Neurol Neurosurg Psychiatry. 1993;56(8):874–877.
   PubMed Web of Science ®Google Scholar
• Friedman J, Friedman H. Fatigue in Parkinson’s disease. Neurology. 1993;43(10):2016–2018.
   PubMed Web of Science ®Google Scholar
• Brown RG, Dittner A, Findley L, Wessely SC. The Parkinson fatigue scale. Parkinsonism Relat Disord. 2005;11(1):49–55.
   PubMed Web of Science ®Google Scholar
• Dogan VB, Koksal A, Dirican A, Baybas S, Dirican A, Dogan GB. Independent effect of fatigue on health-related quality of life in patients with idiopathic Parkinson’s disease. Neurol Sci. 2015;36(12):2221–2226.
   Web of Science ®Google Scholar
• Shulman LM, Taback RL, Rabinstein AA, Weiner WJ. Non-recognition of depression and other non-motor symptoms in Parkinson’s disease. Parkinsonism Relat Disord. 2002;8(3):193–197.
   PubMed Web of Science ®Google Scholar
• Falup-Pecurariu C. Fatigue assessment of Parkinson’s disease patient in clinic: specific versus holistic. J Neural Transm. 2013;120(4):577–581.
   Web of Science ®Google Scholar
• Friedman JH. Fatigue in Parkinson’s disease patients. Curr Treat Options Neurol. 2009;11(3):186–190.
   Web of Science ®Google Scholar
• Kluger BM, Parra V, Jacobson C, et al. The prevalence of fatigue following deep brain stimulation surgery in Parkinson’s disease and association with quality of life. Parkinson’s Dis. 2012;2012:769506.
   PubMed Web of Science ®Google Scholar
• Kluger BM, Krupp LB, Enoka RM. Fatigue and fatigability in neurologic illnesses: proposal for a unified taxonomy. Neurology. 2013;80(4):409–416.
   PubMed Web of Science ®Google Scholar
• Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989;46(10):1121–1123.
   PubMed Web of Science ®Google Scholar
• Manty M, Rantanen T, Era P, Avlund K. Fatigue and depressive symptoms in older people. J Appl Gerontol. 2014;33(4):505–514.
   Web of Science ®Google Scholar
• Garcia-Ruiz PJ, Chaudhuri KR, Martinez-Martin P. Non-motor symptoms of Parkinson’s disease A review…from the past. J Neurol Sci. 2014;338(1–2):30–33.
   Web of Science ®Google Scholar
• Elbers R, van Wegen EE, Rochester L, et al. Is impact of fatigue an independent factor associated with physical activity in patients with idiopathic Parkinson’s disease? Mov Disord. 2009;24(10):1512–1518.
   PubMed Web of Science ®Google Scholar
• Elbers RG, van Wegen EE, Verhoef J, Kwakkel G. Impact of fatigue on health-related quality of life in patients with Parkinson’s disease: a prospective study. Clin Rehabil. 2014;28(3):300–311.
   Web of Science ®Google Scholar
• Miwa H, Miwa T. Fatigue in patients with Parkinson’s disease: impact on quality of life. Int Med. 2011;50(15):1553–1558.
   Web of Science ®Google Scholar
• Ou R, Yang J, Cao B, et al. Progression of non-motor symptoms in Parkinson’s disease among different age populations: a two-year follow-up study. J Neurol Sci. 2016;360:72–77.
   Web of Science ®Google Scholar
• Zis P, Martinez-Martin P, Sauerbier A, et al. Non-motor symptoms burden in treated and untreated early Parkinson’s disease patients: argument for non-motor subtypes. Eur J Neurol. 2015;22(8):1145–1150.
   Web of Science ®Google Scholar
• Zis P, Rizos A, Martinez-Martin P, et al. Non-motor symptoms profile and burden in drug naive versus long-term Parkinson’s disease patients. J Parkinson’s Dis. 2014;4(3):541–547.
   PubMedGoogle Scholar
• Chaudhuri KR, Odin P, Antonini A, Martinez-Martin P. Parkinson’s disease: the non-motor issues. Parkinsonism Relat Disord. 2011;17(10):717–723.
   PubMed Web of Science ®Google Scholar
• Friedman JH, Chou KL. Sleep and fatigue in Parkinson’s disease. Parkinsonism Relat Disord. 2004;10(Suppl 1):S27–S35.
   Google Scholar
• Shulman LM, Taback RL, Bean J, Weiner WJ. Comorbidity of the nonmotor symptoms of Parkinson’s disease. Mov Disord. 2001;16(3):507–510.
   PubMed Web of Science ®Google Scholar
• Friedman JH, Friedman H. Fatigue in Parkinson’s disease: a nine-year follow-up. Mov Disord. 2001;16(6):1120–1122.
   PubMed Web of Science ®Google Scholar
• Saltiel PF, Silvershein DI. Major depressive disorder: mechanism-based prescribing for personalized medicine. Neuropsychiatr Dis Treat. 2015;11:875–888.
   PubMed Web of Science ®Google Scholar
• Prakash KM, Nadkarni NV, Lye WK, Yong MH, Chew LM, Tan EK. A longitudinal study of non-motor symptom burden in Parkinson’s disease after a transition to expert care. Parkinsonism Relat Disord. 2015;21(8):843–847.
   Web of Science ®Google Scholar
• Valkovic P, Harsany J, Hanakova M, Martinkova J, Benetin J. Nonmotor symptoms in early- and advanced-stage Parkinson’s disease patients on dopaminergic therapy: how do they correlate with quality of life? ISRN Neurol. 2014;2014:587302.
   Google Scholar
• Rios Romenets S, Creti L, Fichten C, et al. Doxepin and cognitive behavioural therapy for insomnia in patients with Parkinson’s disease – a randomized study. Parkinsonism Relat Disord. 2013;19(7):670–675.
   PubMed Web of Science ®Google Scholar
• Trotti LM, Bliwise DL. Treatment of the sleep disorders associated with Parkinson’s disease. Neurotherapeutics. 2014;11(1):68–77.
   PubMed Web of Science ®Google Scholar
• Pal PK, Calne S, Samii A, Fleming JA. A review of normal sleep and its disturbances in Parkinson’s disease. Parkinsonism Relat Disord. 1999;5(1–2):1–17.
   Web of Science ®Google Scholar
• Martinez-Ramirez D, De Jesus S, Walz R, et al. A polysomnographic study of Parkinson’s disease sleep architecture. Parkinson’s Dis. 2015;2015:570375.
   Google Scholar
• Gaba DM, Howard SK. Patient safety: fatigue among clinicians and the safety of patients. N Engl J Med. 2002;347(16):1249–1255.
   Web of Science ®Google Scholar
• Weinstein DF. Duty hours for resident physicians – tough choices for teaching hospitals. N Engl J Med. 2002;347(16):1275–1278.
   Web of Science ®Google Scholar
• Steinbrook R. The debate over residents’ work hours. N Engl J Med. 2002;347(16):1296–1302.
   PubMed Web of Science ®Google Scholar
• Kluger BM, Herlofson K, Chou KL, et al. Parkinson’s disease-related fatigue: a case definition and recommendations for clinical research. Mov Disord. 2016;31(5):625–631.
   PubMed Web of Science ®Google Scholar
• Barsevick AM, Irwin MR, Hinds P, et al. Recommendations for high-priority research on cancer-related fatigue in children and adults. J Natl Cancer Inst. 2013;105(19):1432–1440.
   PubMedGoogle Scholar
• Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Int Med. 1994;121(12):953–959.
   PubMed Web of Science ®Google Scholar
• Friedman JH, Alves G, Hagell P, et al. Fatigue rating scales critique and recommendations by the Movement Disorders Society task force on rating scales for Parkinson’s disease. Mov Disord. 2010;25(7):805–822.
   PubMed Web of Science ®Google Scholar
• Dittner AJ, Wessely SC, Brown RG. The assessment of fatigue: a practical guide for clinicians and researchers. J Psychosom Res. 2004;56(2):157–170.
   PubMed Web of Science ®Google Scholar
• Cella D, Yount S, Sorensen M, Chartash E, Sengupta N, Grober J. Validation of the Functional Assessment of Chronic Illness Therapy Fatigue Scale relative to other instrumentation in patients with rheumatoid arthritis.J Rheumatol. 2005;32(5):811–819.
   Google Scholar
• Smets EM, Garssen B, Bonke B, De Haes JC. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res. 1995;39(3):315–325.
   PubMed Web of Science ®Google Scholar
• Lou JS, Kearns G, Oken B, Sexton G, Nutt J. Exacerbated physical fatigue and mental fatigue in Parkinson’s disease. Mov Disord. 2001;16(2):190–196.
   PubMed Web of Science ®Google Scholar
• Fisk JD, Doble SE. Construction and validation of a fatigue impact scale for daily administration (D-FIS). Qual Life Res. 2002;11(3):263–272.
   PubMed Web of Science ®Google Scholar
• Guy W. Clinical global impression. ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: National Institute of Mental Health; 1976.
   Google Scholar
• Goetz CG, Tilley BC, Shaftman SR, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008;23(15):2129–2170.
   PubMed Web of Science ®Google Scholar
• Kluger BM, Brown RP, Aerts S, Schenkman M. Determinants of objectively measured physical functional performance in early to mid-stage Parkinson disease. PM R. 2014;6(11):992–998.
   Google Scholar
• Lou JS, Kearns G, Benice T, Oken B, Sexton G, Nutt J. Levodopa improves physical fatigue in Parkinson’s disease: a double-blind, placebo-controlled, crossover study. Mov Disord. 2003;18(10):1108–1114.
   PubMed Web of Science ®Google Scholar
• Elbers RG, Verhoef J, van Wegen EE, Berendse HW, Kwakkel G. Interventions for fatigue in Parkinson’s disease. Cochrane Database Syst Rev. 2015;10:CD010925.
   Web of Science ®Google Scholar
• Chou KL, Persad CC, Patil PG. Change in fatigue after bilateral subthalamic nucleus deep brain stimulation for Parkinson’s disease. Parkinsonism Relat Disord. 2012;18(5):510–513.
   PubMed Web of Science ®Google Scholar
• Postuma RB, Lang AE, Munhoz RP, et al. Caffeine for treatment of Parkinson disease: a randomized controlled trial. Neurology. 2012;79(7):651–658.
   PubMed Web of Science ®Google Scholar
• Mendonca DA, Menezes K, Jog MS. Methylphenidate improves fatigue scores in Parkinson disease: a randomized controlled trial. Mov Disord. 2007;22(14):2070–2076.
   PubMed Web of Science ®Google Scholar
• Sheng P, Hou L, Wang X, et al. Efficacy of modafinil on fatigue and excessive daytime sleepiness associated with neurological disorders: a systematic review and meta-analysis. PLoS One. 2013;8(12):e81802.
   PubMed Web of Science ®Google Scholar
• Stocchi F, Fossati C, Torti M. Rasagiline for the treatment of Parkinson’s disease: an update. Expert Opin Pharmacother. 2015;16(14):2231–2241.
   PubMed Web of Science ®Google Scholar
• Rascol O, Fitzer-Attas CJ, Hauser R, et al. A double-blind, delayed-start trial of rasagiline in Parkinson’s disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes. Lancet Neurol. 2011;10(5):415–423.
   PubMed Web of Science ®Google Scholar
• Schifitto G, Friedman JH, Oakes D, et al. Fatigue in levodopa-naive subjects with Parkinson disease. Neurology. 2008;71(7):481–485.
   PubMed Web of Science ®Google Scholar
• Ray Chaudhuri K, Martinez-Martin P, Antonini A, et al. Rotigotine and specific non-motor symptoms of Parkinson’s disease: post hoc analysis of RECOVER. Parkinsonism Relat Disord. 2013;19(7):660–665.
   PubMed Web of Science ®Google Scholar
• Zagmutt FJ, Tarrants ML. Indirect comparisons of adverse events and dropout rates in early Parkinson’s disease trials of pramipexole, ropinirole, and rasagiline. Int J Neurosci. 2012;122(7):345–353.
   PubMed Web of Science ®Google Scholar
• Ondo WG, Shinawi L, Davidson A, Lai D. Memantine for non-motor features of Parkinson’s disease: a double-blind placebo controlled exploratory pilot trial. Parkinsonism Relat Disord. 2011;17(3):156–159.
   PubMed Web of Science ®Google Scholar
• Russell IJ, Holman AJ, Swick TJ, et al. Sodium oxybate reduces pain, fatigue, and sleep disturbance and improves functionality in fibromyalgia: results from a 14-week, randomized, double-blind, placebo-controlled study. Pain. 2011;152(5):1007–1017.
   PubMed Web of Science ®Google Scholar
• Ondo WG, Perkins T, Swick T, et al. Sodium oxybate for excessive daytime sleepiness in Parkinson disease: an open-label polysomnographic study. Arch Neurol. 2008;65(10):1337–1340.
   PubMedGoogle Scholar
• McNeely ME, Duncan RP, Earhart GM. Impacts of dance on non-motor symptoms, participation, and quality of life in Parkinson disease and healthy older adults. Maturitas. 2015;82(4):336–341.
   PubMed Web of Science ®Google Scholar
• Abrantes AM, Friedman JH, Brown RA, et al. Physical activity and neuropsychiatric symptoms of Parkinson disease. J Geriatr Psychiatry Neurol. 2012;25(3):138–145.
   PubMed Web of Science ®Google Scholar
• Cugusi L, Solla P, Zedda F, et al. Effects of an adapted physical activity program on motor and non-motor functions and quality of life in patients with Parkinson’s disease. NeuroRehabilitation. 2014;35(4):789–794.
   Web of Science ®Google Scholar
• Canning CG, Allen NE, Dean CM, Goh L, Fung VS. Home-based treadmill training for individuals with Parkinson’s disease: a randomized controlled pilot trial. Clin Rehabil. 2012;26(9):817–826.
   PubMed Web of Science ®Google Scholar
• Winward C, Sackley C, Meek C, et al. Weekly exercise does not improve fatigue levels in Parkinson’s disease. Mov Disord. 2012;27(1):143–146.
   PubMed Web of Science ®Google Scholar
• Cugusi L, Solla P, Serpe R, et al. Effects of a Nordic Walking program on motor and non-motor symptoms, functional performance and body composition in patients with Parkinson’s disease. NeuroRehabilitation. 2015;37(2):245–254.
   PubMed Web of Science ®Google Scholar
• Kluger BM, Rakowski D, Christian M, et al. Randomized, controlled trial of acupuncture for fatigue in Parkinson’s disease. Mov Disord. In press2016.
   Google Scholar
• Ghahari S, Leigh Packer T, Passmore AE. Effectiveness of an online fatigue self-management programme for people with chronic neurological conditions: a randomized controlled trial. Clin Rehabil. 2010;24(8):727–744.
   PubMed Web of Science ®Google Scholar
• Cochrane GD, Rizvi S, Abrantes AM, Crabtree B, Cahill J, Friedman JH. The association between fatigue and apathy in patients with either Parkinson’s disease or multiple sclerosis. Parkinsonism Relat Disord. 2015;21(9):1093–1095.
   Web of Science ®Google Scholar
• Lou JS, Dimitrova DM, Park BS, et al. Using modafinil to treat fatigue in Parkinson disease: a double-blind, placebo-controlled pilot study. Clin Neuropharmacol. 2009;32(6):305–310.
   PubMed Web of Science ®Google Scholar
• Ondo WG, Fayle R, Atassi F, Jankovic J. Modafinil for daytime somnolence in Parkinson’s disease: double blind, placebo controlled parallel trial.J Neurol Neurosurg Psychiatry. 2005;76(12):1636–1639.
   Google Scholar
• Tyne HL, Taylor J, Baker GA, Steiger MJ. Modafinil for Parkinson’s disease fatigue. J Neurol. 2010;257(3):452–456.
   Web of Science ®Google Scholar
• Olanow CW, Rascol O, Hauser R, et al. A double-blind, delayed-start trial of rasagiline in Parkinson’s disease. N Engl J Med. 2009;361(13):1268–1278.
   PubMed Web of Science ®Google Scholar